Clinical trial
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
NCT00311350 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00311350 |
|---|---|
| Title | Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects |
| Official title | Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Postoperative Complications, Constipation |
| Intervention type | Drug |
| Interventions | MOA-728 |
| Enrollment | 48 |
| Start date | Mar 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Apr 5, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: